| 注册
首页|期刊导航|中国临床药理学与治疗学|基于物质映射的中药开发

基于物质映射的中药开发

阳国平 裴奇 彭金富

中国临床药理学与治疗学2017,Vol.22Issue(2):121-123,3.
中国临床药理学与治疗学2017,Vol.22Issue(2):121-123,3.

基于物质映射的中药开发

Development of traditional Chinese medicine based on material mapping

阳国平 1裴奇 2彭金富3

作者信息

  • 1. 中南大学湘雅三医院临床药理中心,长沙410013,湖南
  • 2. 湖南省药制剂优化与早期临床评价工程技术研究中心,长沙410013,湖南
  • 3. 药物临床评价技术国家地方联合工程实验室,长沙410013,湖南
  • 折叠

摘要

Abstract

This paper proposed the concept of material mapping of traditional Chinese medicine (TCM),which is information or signals in a variety of media and biological effects of substances with drug effects that can be detected using existing techniques.Features of material mapping in different media can be qualitatively and quantitatively described using a three-dimensional map.Based on the material mapping,TCM development model is different from western medicine,which performs early phase (0 phases) clinical trials to obtain clinical efficacy information.PD/PK researches usually study the efficacy,yet the material of PK study does not necessarily have real effects,but a variety of components related to the efficacy.The in vivo exposure of the drug can be described by the VUC (volume under the curved surface).PD/PK study provides human evaluation criteria for subsequent formulation optimization studies.Quality control of TCM should cover the whole process from materials to the finished product,and qualitative & quantitative descriptions of material mapping are important components of quality control system.Before marketing,TCM should be validated by strict randomized and controlled clinical trials.The population selection and evaluation indexes may reflect the characteristics of TCM,but there is no difference of the logic reasoning of science between western medicine and TCM.

关键词

中药物质映射/中药0期临床试验/PD/PK/曲面下体积/全程质控标准体系

Key words

TCM material mapping/TCM phase 0 clinical trials/PD/PK/VUC/whole quality control system

分类

医药卫生

引用本文复制引用

阳国平,裴奇,彭金富..基于物质映射的中药开发[J].中国临床药理学与治疗学,2017,22(2):121-123,3.

基金项目

湖南省科技计划基金项目(2015TP2005) (2015TP2005)

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量1
|
下载量0
段落导航相关论文